Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New antimicrobials.

J W Stone, A J Davies

    British Journal of Hospital Medicine
    |August 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Recent antimicrobial developments focus on beta-lactams and quinolones to combat resistance. New antibiotics available in the UK and those in clinical trials are reviewed.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Metabolic heterogeneity-based radiomic model predicts treatment outcomes of primary mediastinal B-cell lymphoma patients in the IELSG37 study.

    British journal of haematology·2026
    Same author

    Early but reversible haemostatic changes in a-symptomatic females expressing COVID-19 antibodies.

    Thrombosis research·2022
    Same author

    3-D ocean particle tracking modeling reveals extensive vertical movement and downstream interdependence of closed areas in the northwest Atlantic.

    Scientific reports·2020
    Same author

    Growth of single-layer boron nitride dome-shaped nanostructures catalysed by iron clusters.

    Nanoscale·2016
    Same author

    Richard keeve gershon (1932-1983).

    Immunology today·2014
    Same author

    Consensus in chronic ankle instability: aetiology, assessment, surgical indications and place for arthroscopy.

    Orthopaedics & traumatology, surgery & research : OTSR·2013
    Same journal

    The autopsy in the 1990s.

    British journal of hospital medicine·1999
    Same journal

    Screening for breast cancer.

    British journal of hospital medicine·1999
    Same journal

    Cost-effective monotherapy of concomitant benign prostatic hyperplasia and hypertension.

    British journal of hospital medicine·1999
    Same journal

    Liposarcoma: a review of current diagnosis and management.

    British journal of hospital medicine·1999
    Same journal

    How to do it in surgery: laparoscopic rectopexy.

    British journal of hospital medicine·1999
    Same journal

    The management of ovarian cancer.

    British journal of hospital medicine·1999
    See all related articles

    Area of Science:

    • Pharmacology and Infectious Diseases
    • Medicinal Chemistry

    Background:

    • Antimicrobial resistance is a growing global health concern.
    • Recent pharmaceutical efforts have focused on beta-lactam and quinolone antibiotics.
    • Development aims to overcome resistance and broaden antimicrobial spectrums.

    Purpose of the Study:

    • To review recently available antibiotics in the UK.
    • To discuss novel antimicrobial compounds in current clinical trials.
    • To highlight key advancements in antimicrobial drug development.

    Main Methods:

    • Literature review of recent pharmaceutical developments.
    • Analysis of newly approved antibiotics in the UK market.
    • Survey of antimicrobial agents in clinical development phases.

    Related Experiment Videos

    Main Results:

    • Beta-lactams and quinolones represent major recent antimicrobial advancements.
    • New agents target resistance and offer broader or specific pathogen coverage.
    • Several novel compounds are progressing through clinical trials.

    Conclusions:

    • The pharmaceutical industry is actively developing new antimicrobials, particularly beta-lactams and quinolones.
    • Ongoing research addresses the critical challenge of antimicrobial resistance.
    • The reviewed antibiotics and trial compounds offer future therapeutic options.